Polyp Biopsy Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Polyp Biopsy Market?

The polyp biopsy market size has demonstrated robust expansion in recent years. It is anticipated to grow from $1.27 billion in 2024 to $1.39 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.7%. The historical increase can be attributed to heightened awareness of colorectal cancer screening, a rising incidence of gastrointestinal disorders, the development of hospital and diagnostic infrastructure, government-supported screening programs, and advancements in biopsy forceps technology.

The polyp biopsy market is projected to experience substantial expansion over the next few years. It is anticipated to reach $1.91 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.3%. This anticipated growth over the forecast period is propelled by several factors, including an increasing demand for minimally invasive procedures, a surge in the adoption of disposable biopsy devices, greater healthcare investments focused on early cancer detection, broadened insurance coverage for diagnostic processes, and an aging worldwide population boosting screening participation. Key trends during this period are expected to encompass the incorporation of artificial intelligence into biopsy analysis, the emergence of robotic-assisted biopsy techniques, an increased utilization of disposable and single-use devices, a developing preference for outpatient and ambulatory care facilities, and a general move towards personalized medicine and precision diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

Which Drivers Are Shaping The Polyp Biopsy Industry’s Market Share?

The rising incidence of colorectal cancer is anticipated to drive the expansion of the polyp biopsy market in the future. Colorectal cancer, a malignant condition, originates in the colon or rectum. It stems from the abnormal and uncontrolled proliferation of epithelial cells within the large intestine and is known for its capacity to infiltrate nearby tissues and spread to distant organs. The escalating occurrence of colorectal cancer is chiefly fueled by common dietary habits rich in processed foods and deficient in fiber. These habits foster persistent inflammation, modify the gut microbiota, and aid in the formation of precancerous lesions that may advance to malignancy eventually. Polyp biopsy plays a crucial role in lessening the effects of the increasing prevalence of colorectal cancer. It achieves this by allowing for the early discovery and histopathological assessment of potentially problematic lesions, consequently facilitating prompt treatment and hindering the advancement of the disease. As an illustration, for 2025, the American Cancer Society (ACS), a US-based non-profit organization, estimates that 107,320 new cases of colon cancer and 46,950 cases of rectal cancer are anticipated to be diagnosed in the United States, alongside approximately 52,900 fatalities from these specific cancers. Consequently, the expanding prevalence of colorectal cancer is propelling the growth of the polyp biopsy market.

What Are The Different Segment Classifications Within The Polyp Biopsy Market?

The polyp biopsy market covered in this report is segmented as

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy, Laryngoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Distribution Channel: Online Sales Channels, Retail Pharmacies, Other Distribution Channels

4) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Screening Colonoscopy, Therapeutic Colonoscopy, Virtual Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy, Anal Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy, Surveillance Esophagogastroduodenoscopy, Screening Esophagogastroduodenoscopy

4) By Laryngoscopy: Direct Laryngoscopy, Indirect Laryngoscopy, Flexible Laryngoscopy, Rigid Laryngoscopy

Which Trends Are Impacting The Polyp Biopsy Market?

Leading companies active in the polyp biopsy market are concentrating on creating cutting-edge developments, like AI-assisted detection systems, to improve the identification of colorectal polyps and aid in the early discovery of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging in real-time, pinpointing potential abnormalities and issuing visual alerts to clinicians, thereby supporting clinical decision-making without engaging in therapeutic interventions. For example, in September 2024, Odin Medical Ltd., a US-based medical technology company connected with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. This CADDIE device utilizes cloud-based artificial intelligence to analyze colonoscopy video instantaneously and highlight areas where colorectal polyps are suspected, enabling endoscopists to make informed choices during procedures. Clinical trials showed that the system improves the adenoma detection rate without increasing procedural duration or risk, emphasizing its capability to enhance early detection and patient care.

Which Major Firms Are Strengthening Their Position In The Polyp Biopsy Industry?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., Cooper Surgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

How Is Polyp Biopsy Market Demand Varying Across Different Regions?

North America was the largest region in the polyp biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polyp biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28304&type=smp

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2025, By The Business Research Company

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Kidney Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795